D. Jarvis, R. Newson, J. Lotvall, D. Hastan, P. Tomassen et al., Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe

, Allergy, vol.67, issue.1, pp.91-99, 2012.

J. U. Ponikau, D. A. Sherris, G. M. Kephart, E. B. Kern, T. A. Gaffey et al., Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis:is the histopathology similar to asthma? The Journal of allergy and clinical immunology, vol.112, pp.877-82, 2003.

O. Matsuno, E. Ono, R. Takenaka, T. Okubo, K. Takatani et al., Asthma and sinusitis: association and implication, Int Arch Allergy Immunol, vol.147, issue.1, pp.52-60, 2008.

W. J. Fokkens, V. J. Lund, J. Mullol, C. Bachert, I. Alobid et al., European position paper on rhinosinusitis and nasal polyps (EPOS) 2012, Rhinol Suppl, vol.23, pp.1-298, 2012.

P. Small, P. K. Keith, and H. Kim, Allergic rhinitis, Allergy Asthma Clin Immunol, vol.14, issue.2, p.51, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-00875331

R. M. Rosenfeld, Clinical practice guideline on adult sinusitis, Otolaryngol Head Neck Surg, vol.137, pp.365-77, 2007.

D. L. Hamilos, Chronic rhinosinusitis: Epidemiology ans medical management, Clin Rev Allergy Immunol, 2011.

B. K. Tan, R. K. Chandra, J. Pollak, A. Kato, D. B. Conley et al., Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis

, J Allergy Clin Immunol, vol.131, pp.1350-60, 2013.

C. De-dorlodot, M. Horoi, P. Lefebvre, S. Collet, B. Bertrand et al., French adaptation and validation of the Sino-Nasal Outcome Test-22: a prospective cohort study on quality of life among 422 subjects, Clinical Otolaryngology, 2015.

W. Fokkens, V. Lund, C. Bachert, P. Clement, P. Helllings et al., EAACI position paper on rhinosinusitis and nasal polyps executive summary, Allergy, vol.60, issue.5, pp.583-601, 2005.

M. Koennecke, L. Klimek, J. Mullol, P. Gevaert, and B. Wollenberg, Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities, Allergo J Int, vol.27, issue.2, pp.56-65

L. Com-ruelle, B. Crestin, and D. S. , asthme en France selon les stades de sévérité. Rapport de l'Institut de Recherche et de Documentation en Economie de la Santé Février, p.24, 2000.

P. Chanez, S. E. Wenzel, G. P. Anderson, and I. Vachier, Severe asthma in adults: What are the important questions?, J Allergy Clin Immunol, vol.119, issue.6, pp.1337-1348, 2007.

A. Liou, J. R. Grubb, K. B. Schechtman, and D. L. Hamilos, Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care, Chest, vol.124, pp.1781-1789, 2003.

C. Bachert, S. E. Claeys, P. Tomassen, T. Van-zele, and N. Zhang, Rhinosinusitis and asthma: a link for asthma severity, Curr Allergy Asthma Rep, vol.10, pp.194-201, 2010.

D. E. Shaw, A. R. Sousa, S. J. Fowler, and K. F. Chung, Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort, Eur Respir J, vol.46, pp.1308-1321, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01969506

G. A. Settipane and F. H. Chafee, Nasal polyps in asthma and rhinitis. A review of 6,037 patients. The Journal of allergy and clinical immunology, vol.59, pp.17-21, 1977.

G. Hens and . Pw, The nose: gatekeeper and trigger of bronchial disease, Rhinology, vol.44, issue.3, pp.179-87, 2006.

A. Johansson, M. Bende, E. Millqvist, and B. Bake, Nasobronchial relationship after cold air provocation. Respiratory medicine, vol.94, pp.1119-1141, 2000.

G. Hens, U. Raap, J. Vanoirbeek, I. Meyts, I. Callebaut et al., Selective Nasal Allergen Provocation Induces Substance P-mediated Bronchial Hyperresponsiveness, Am J Respir Cell Mol Biol, 2010.

J. U. Ponikau, D. A. Sherris, G. M. Kephart, E. B. Kern, T. A. Gaffey et al., Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?, J Allergy clin immunology, vol.112, issue.5, pp.877-82, 2003.

D. L. Hamilos, D. Y. Leung, R. Wood, L. Cunningham, D. K. Bean et al., Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis, J Allergy Clin Immunol, vol.96, issue.4, pp.537-581, 1995.

J. Bousquet, P. Van-cauwenberge, and N. Khaltaev, Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, vol.108, issue.5, pp.147-334, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02099400

P. Giavina-bianchi, M. V. Aun, P. Takejima, J. Kalil, and R. C. Agondi, United airway disease: current perspectives, Asthma Allergy, vol.9, pp.93-100, 2016.

I. D. Pavord, R. Beasley, A. Agusti, G. P. Anderson, E. Bel et al., After asthmaredefining airways diseases, Lancet, vol.391, p.10118, 2018.

M. R. Edwards, S. Saglani1, J. Schwarze, and S. L. Johnston, Addressing unmet needs in understanding asthma mechanisms, Eur Respir J, vol.49, p.1602448, 2017.

E. H. Bel, Clinical phenotypes of asthma, Curr Opin Pulm Med, vol.10, pp.44-50, 2004.

W. C. Moore, D. A. Meyers, S. E. Wenzel, W. G. Teague, H. Li et al., Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program, Am J Respir Crit Care Med, vol.181, pp.315-338, 2010.

S. E. Wenzel, Asthma phenotypes : the evolution from clinical to molecular approaches, Nat Med, vol.18, pp.716-741, 2012.

P. Haldar, Noneosinophilic asthma, J Allergy Clin Immunolog, 2007.

P. G. Woodruff, T-helper type 2-driven inflammation defines major subphenotypes of asthma, Am. J. Respir. Crit. Care Med, vol.180, pp.388-427, 2009.

P. Haldar, C. E. Brightling, B. Hargadon, W. Monteiro, A. Sousa et al., Mepolizumab and exacerbations of refractory eosinophilic asthma, N Eng J Med, vol.360, pp.973-84, 2009.

I. D. Pavord, S. Korn, P. Howarth, E. R. Bleecker, R. Buhl et al., Mepolizumab for severe eosinophilic asthma (DREAM): a multicenter, double-blind, placebo-controlled trial, Lancet, vol.380, pp.651-660, 2012.

M. Castro, J. Zangrilli, M. E. Wechsler, E. D. Bateman, G. G. Brusselle et al., Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts : results from two multicenter, parallel, double-blind, randomized, placebo-controlled, phase 3 trials, Lancet Respir Med, vol.3, pp.355-66, 2015.

P. Nair, S. Wenzel, K. F. Rabe, A. Bourdin, N. L. Lugogo et al., Oral glucocorticoid-sparing effect of benralizumab in severe asthma, N Eng J Med, vol.376, pp.2448-58, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01761510

M. Samter and R. F. Beers, Concerning the nature of intolerance to aspirin, J. Allergy, vol.40, pp.281-293, 1967.

M. Bresciani, L. Paradis, D. Roches, A. Chanez, and P. , Rhinosinusitis in severe asthma, J Allergy Clin Immunolog, vol.107, pp.73-80, 2001.

Y. J. Huang, The airway microbiome in patients with severe asthma: Associations with disease features and severity, J. Allergy Clin. Immunol, vol.136, pp.874-884, 2015.

B. J. Green, Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma, PLOS ONE, vol.9, p.100645, 2014.

. Serment-d'hippocrate,

, Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité?

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté?,volonté?, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégritéóu leur dignité?.dignité?. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité?deshérité?des circonstances pour forcer les consciences

, Admise dans l'intimité?desintimité?des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité?.adversité?

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses